Results
24
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
24 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
YOU New | US$26.66 | 1.1% | 22.3% | US$3.7b | US$32.13 | PE31.5x | E27.1% | 3.1% | ||
PRGS | US$66.38 | -3.7% | 20.8% | US$2.8b | US$73.29 | PE34.5x | E24.5% | 0% | ||
KD | US$34.51 | -2.3% | 69.2% | US$8.0b | US$38.40 | PS0.5x | E66.9% | n/a | ||
SMAR | US$56.01 | -0.02% | 17.5% | US$7.8b | US$56.48 | PS7.2x | E62.8% | n/a | ||
ZS | US$187.38 | -5.6% | -15.5% | US$28.8b | US$225.77 | PS12.5x | E39.7% | n/a | ||
OKTA | US$83.28 | 1.6% | -6.8% | US$14.3b | US$103.55 | PS5.6x | E36.3% | n/a | ||
CWAN | US$28.70 | -2.9% | 43.1% | US$7.1b | US$33.00 | PE9895.5x | E101.7% | n/a | ||
SDCH New | US$0.04 | -0.5% | 98.1% | US$9.0m | US$0.23 | PS1.2x | E138.6% | n/a | ||
ORCL | US$169.66 | -2.2% | 59.8% | US$474.5b | US$196.55 | PE40.8x | E16.6% | 0.9% | ||
DT | US$54.64 | 0.4% | -1.3% | US$16.3b | US$62.11 | PE99.9x | E20.7% | n/a | ||
ADEA | US$13.66 | -5.0% | 15.1% | US$1.5b | US$16.33 | PE36.1x | E81.9% | 1.5% | ||
TEAM | US$257.26 | -7.7% | 6.8% | US$67.0b | US$271.60 | PS14.7x | E58.4% | n/a | ||
CD | US$8.45 | -1.2% | 7.0% | US$3.1b | US$10.55 | PE26.6x | E25.6% | n/a | ||
PEGA | US$95.24 | 0.7% | 91.5% | US$8.2b | US$96.10 | PE66.5x | E23.9% | 0.1% | ||
ENFN | US$10.63 | -0.2% | 9.8% | US$1.4b | US$9.61 | PE367.7x | E74.8% | n/a | ||
INTU | US$643.39 | -2.0% | 3.1% | US$180.2b | US$728.08 | PE61.7x | E17.3% | 0.6% | ||
CRWD New | US$362.29 | -1.6% | 41.7% | US$89.2b | US$375.18 | PE704.3x | E42.1% | n/a | ||
CXDO | US$5.21 | 0.8% | 18.9% | US$141.2m | US$7.41 | PE114.7x | E30.9% | 0% | ||
SMWB | US$14.56 | 13.9% | 179.5% | US$1.2b | US$14.88 | PS4.9x | E126.3% | n/a | ||
INTA | US$65.19 | -5.0% | 69.9% | US$5.0b | US$69.56 | PS11.3x | E79.1% | n/a | ||
DDOG | US$149.46 | -2.3% | 22.0% | US$50.8b | US$158.29 | PE264.3x | E22.8% | n/a | ||
NCNO | US$35.22 | -0.7% | 5.3% | US$4.1b | US$42.27 | PS7.8x | E118.9% | n/a | ||
HCP New | US$34.27 | 1.5% | 46.3% | US$7.0b | US$34.86 | PS10.7x | E48.8% | n/a | ||
ALKT | US$39.12 | -1.2% | 60.0% | US$3.9b | US$44.60 | PS12.5x | E102.7% | n/a |